Hexapeptide GHRP
2mg / vial
Hexarelin is a synthetic hexapeptide and one of the most potent GHRPs studied in research. Beyond its GH-stimulating properties, it has attracted significant research interest for its cardioprotective effects — a mechanism that appears to be partially independent of its GH-releasing action.
Hexarelin (His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic analogue of GHRP-6 with enhanced potency. It binds to both the GHS-R1a (ghrelin) receptor and the CD36 receptor — the latter being the basis for its investigated cardioprotective properties.
At the pituitary, Hexarelin stimulates GH release via GHS-R1a binding — more potently than most other GHRPs. Independently, its CD36 binding has been studied in models of cardiac ischaemia, where it appears to protect cardiomyocytes from apoptosis and reduce infarct size. These two mechanisms make it a unique dual-action research compound.
Research on Hexarelin spans GH axis studies, cardiac protection models, and investigation of its unique CD36 receptor interactions. Its cardioprotective studies have been conducted independently of its GH-stimulating effects, suggesting a separate mechanism of action.
Commonly researched with